Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) to Prevent SARS-CoV-2 Infection
type: Thing
description: clinical trial
additional property: PropertyValue
  property ID: P17
  value: United States
additional property: PropertyValue
  property ID: P31
  value: clinical trial
additional property: PropertyValue
  property ID: P580
  value: March 16, 2020
additional property: PropertyValue
  property ID: P582
  value: November 22, 2021
additional property: PropertyValue
  property ID: P859
  value: National Institute of Allergy and Infectious Diseases
additional property: PropertyValue
  property ID: P921
  value: immunogenicity
additional property: PropertyValue
  property ID: P921
  value: COVID-19
additional property: PropertyValue
  property ID: P921
  value: safety
additional property: PropertyValue
  property ID: P932
  value: 7556339
additional property: PropertyValue
  property ID: P1132
  value: +120
additional property: PropertyValue
  property ID: P1476
  value: Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) to Prevent SARS-CoV-2 Infection
additional property: PropertyValue
  property ID: P1476
  value: Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for Prophylaxis of SARS-CoV-2 Infection (COVID-19)
additional property: PropertyValue
  property ID: P2899
  value: +18
additional property: PropertyValue
  property ID: P3098
  value: NCT04283461
additional property: PropertyValue
  property ID: P4135
  value: +99
additional property: PropertyValue
  property ID: P4844
  value: mRNA-1273 vaccine
additional property: PropertyValue
  property ID: P6099
  value: phase I clinical trial
additional property: PropertyValue
  property ID: P8363
  value: interventional study
confidence:
  popularity graph score:
    score: 0.0
    score pct: 0
    tier: long_tail
    components:
      sitelinks: 0
      sitelinks norm: 0.0
      unique citations: 1
      unique citations norm: 0.0
      monthly pageviews: 0
      monthly pageviews norm: 0.0
  sitelinks: 0
  unique citations: 1
  monthly pageviews: 0
  yearly pageviews: 0
  tier: long_tail
claims:
  P17:
    value: Q30
    source count: 0
    confidence: 0.0
    value label: United States
  P31:
    value: Q30612
    source count: 0
    confidence: 0.0
    value label: clinical trial
  P580:
    value: +2020-03-16T00:00:00Z
    source count: 0
    confidence: 0.0
  P582:
    value: +2021-11-22T00:00:00Z
    source count: 0
    confidence: 0.0
  P859:
    value: Q3519875
    source count: 0
    confidence: 0.0
    value label: National Institute of Allergy and Infectious Diseases
  P921:
    value: Q1660197
    source count: 0
    confidence: 0.0
    value label: immunogenicity
  P921:
    value: Q84263196
    source count: 0
    confidence: 0.0
    value label: COVID-19
  P921:
    value: Q10566551
    source count: 0
    confidence: 0.0
    value label: safety
  P921:
    value: Q82069695
    source count: 0
    confidence: 0.0
    value label: SARS-CoV-2
  P921:
    value: Q87775025
    source count: 1
    confidence: 0.2
    value label: mRNA-1273 vaccine
  P932:
    value: 7556339
    source count: 0
    confidence: 0.0
  P1132:
    value:
      unit: 1
      amount: +120
    source count: 0
    confidence: 0.0
  P1476:
    value: Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) to Prevent SARS-CoV-2 Infection
    source count: 0
    confidence: 0.0
  P1476:
    value: Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for Prophylaxis of SARS-CoV-2 Infection (COVID-19)
    source count: 0
    confidence: 0.0
  P2899:
    value:
      unit: http://www.wikidata.org/entity/Q24564698
      amount: +18
    source count: 0
    confidence: 0.0
  P3098:
    value: NCT04283461
    source count: 0
    confidence: 0.0
  P4135:
    value:
      unit: http://www.wikidata.org/entity/Q24564698
      amount: +99
    source count: 0
    confidence: 0.0
  P4844:
    value: Q87775025
    source count: 1
    confidence: 0.2
    value label: mRNA-1273 vaccine
  P6099:
    value: Q5452194
    source count: 0
    confidence: 0.0
    value label: phase I clinical trial
  P8363:
    value: Q9164018
    source count: 0
    confidence: 0.0
    value label: interventional study
citations:
  retrieved: 2020-07-12
meta:
  wikidata id: Q87775009
  domain: clinical_trial
  level: standard
  html url: https://4ort.xyz/entity/safety-and-immunogenicity-study-of-2019-ncov-vaccine-mrna-1273-to-prevent-sars-cov-2-infection
  markdown url: https://4ort.xyz/entity/safety-and-immunogenicity-study-of-2019-ncov-vaccine-mrna-1273-to-prevent-sars-cov-2-infection.md
  facts url summary: https://4ort.xyz/entity/safety-and-immunogenicity-study-of-2019-ncov-vaccine-mrna-1273-to-prevent-sars-cov-2-infection/facts.json
  facts url standard: https://4ort.xyz/entity/safety-and-immunogenicity-study-of-2019-ncov-vaccine-mrna-1273-to-prevent-sars-cov-2-infection/facts.json
  facts url full: https://4ort.xyz/entity/safety-and-immunogenicity-study-of-2019-ncov-vaccine-mrna-1273-to-prevent-sars-cov-2-infection/facts.json
  data source: Wikidata (CC0 / public domain)
  license: https://creativecommons.org/publicdomain/zero/1.0/
  api version: v1
  served at: 2026-08-13T23:18:34.415430Z
  entity updated at: 2026-05-03T18:28:36.114423+00:00Z
  entity created at: 2026-05-03T15:31:03.238104+00:00Z